vimarsana.com

Page 2 - புளோரிடா அட்லாண்டிக் பல்கலைக்கழகம் கல்லூரி ஆஃப் பொறியியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New method predicts if COVID-19 clinical trials will be completed or suspended

New method predicts if COVID-19 clinical trials will be completed or suspended In order to win the battle against COVID-19, studies to develop vaccines, drugs, devices and re-purposed drugs are urgently needed. Randomized clinical trials are used to provide evidence of safety and efficacy as well as to better understand this novel and evolving virus. As of July 15, more than 6,180 COVID-19 clinical trials have been registered through ClinicalTrials.gov, the national registry and database for privately and publicly funded clinical studies conducted around the world. Knowing which ones are likely to succeed is imperative. Researchers from Florida Atlantic University s College of Engineering and Computer Science are the first to model COVID-19 completion versus cessation in clinical trials using machine learning algorithms and ensemble learning. The study, published in

Highlighting the real successes of AI

Highlighting the real successes of AI Highlighting the real successes of AI Despite the hype, especially around self-driving cars, AI is writing code, designing Google chip floor plans, and telling us how much to trust it. Credit: Dreamstime Given just how much of the AI hype is just that hype it’s easy to forget that a wide range of companies are having real success with AI. No, I’m not talking about Tesla’s continued errant marketing of AI-infused “full self-driving.” As analyst Benedict Evans writes, “Version nine of ‘Full Self-Driving’ is shipping soon (in beta) and yet will not in fact be full self-driving, or anything close to it.” Rather, I’m talking about the kinds of real-world examples listed by Mike Loukides, some of which involve not-so-full self driving.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.